You are here

LUM001

Shire Acquisition Bolsters Its Rare, And Maybe Not-So-Rare, Disease Portfolio

Seeking Alpha

Mon, 05/19/14 - 09:23 am

Lumena Pharmaceuticals

Lumena swings for a $75M IPO to bear down on liver diseases

Fierce Biotech

Thu, 04/3/14 - 09:30 am

Lumena Pharmaceuticals